MIVOLIS Sweetener Tablets 2400 pcs. - Table Sweeteners | Germany

Product Information

Administrare concomitentă de acetilsalicilic (1000 mg de trei ori pe zi) la voluntari sănătoşi a dus la creşterea AUC (10%) şi Cmax (24%) pentru meloxicam. Anticonceptionalele intra in categoria metodelor contraceptive si reprezinta forma farmaceutica a acestora ce sunt administrate sub forma de pilule sau tablete (comprimate) ori chiar si in forma de unguente sau creme. GI bleeding, ulceration or perforation, which can be fatal, has been reported with all NSAIDs at anytime during treatment, with or without warning symptoms or a previous history of serious GI events. Caution should be exercised when treating patients with a history of upper gastrointestinal disease and in patients receiving treatment with anticoagulants. Patients with GI symptoms should be monitored. Movalis therapy should cease if peptic ulceration or GI ulceration or bleeding occurs.

Poliartrită reumatoidă: 15 mg/zi. În funcţie de răspunsul terapeutic, doza poate fi redusă la 7,5 mg/zi. Spondilită anchilopozantă: 15 mg/zi. Movalis nu trebuie administrat bolnavilor cu manifestări de astm, polipi nazali, angioedem sau urticarie ca urmare a administrării de acid acetilsalicilic sau alte AINS. collapse or fainting, shortness of breath or tiredness, fast or irregular heartbeat (also called palpitations), chest pain, swollen or sore leg veinssinusitis, a condition causing a feeling of tension or fullness of the nose, cheeks and behind your eyes Make sure you know how you react to it before you drive a car, operate machinery, or do anything else that could be dangerous if you are not alert. Meloxicam crosses the placental barrier. There are no adequate, well controlled studies in pregnant women. Meloxicam should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

The recommended dose of Movalis is 7.5 mg once daily, to be swallowed with fluid, in conjunction with food. Depending on the adequacy of response, the severity of the arthritic condition and the patient’s concomitant diseases, the dose may be increased to 15 mg/day. Patients should generally be maintained on the lowest dose consistent with achieving a satisfactory therapeutic response. Overdosage

you are currently taking other medicines known as: sulfinpyrazone (used to treat gout), fluconazole (used to treat fungal infections) or certain sulfur antibiotics (eg. sulfaphenazole or sulfamethoxazole).

For patients with kidney problems undergoing dialysis, the maximum recommended daily dose is 7.5 mg. Once daily dosing of meloxicam 7.5 mg (n = 153) and 15 mg (n = 156) showed a consistently more efficacious response than placebo (n = 155) in a 12 week trial in patients with osteoarthritis of the knee or hip. Efficacy was measured by global assessment of disease activity, global assessment of pain and arthritic condition, as measured by the WOMAC (Western Ontario and McMaster University) Osteoarthritis Index. Both doses of meloxicam were also shown to be comparable to diclofenac 50 mg twice daily (bid) (n = 152) with regard to efficacy, with a lower incidence of gastrointestinal (GI) adverse events when compared to diclofenac.

Pharmacology

Anticoagulante orale, ticlopidină, heparină, trombolitice: risc crescut de sângerare; dacă administrarea lor concomitentă nu poate fi evitată, se impune o monitorizate atentă a efectului anticoagulant; Colestyramine. Colestyramine binds to meloxicam in the gastrointestinal tract leading to a faster elimination of meloxicam.

infections in your urinary tract, eg. the need to pass urine more frequently than normal, any change in the amount or colour of your urine (red or brown) or painful urination Angiotensin II receptor antagonists. NSAIDs and angiotensin II receptor antagonists as well as ACE inhibitors exert a synergistic effect on the decrease of glomerular filtration. In patients with pre-existing renal impairment this may lead to acute renal failure. Sarcina si alaptare: nu s-au observat efecte teratogene in testarea pre-clinica. Movalis nu se administreaza pe parcursul sarcinii si alaptarii.

Diuretice: tratamentul cu AINS poate produce insuficienţă renală acută, la pacienţii deshidrataţi. Bolnavii sub tratament cu Movalis şi diuretice trebuie hidrataţi corespunzător, iar funcţia renală trebuie monitorizată înainte de începerea tratamentului. There is significant biliary and/or enteral secretion of the drug. This was demonstrated when oral administration of colestyramine following a single IV dose of meloxicam decreased the AUC of meloxicam by 50%. Meloxicam is eliminated from the body with a mean elimination half-life of 20 hours. Plasma clearance ranges from 7-9 mL/min. Immediately telephone your doctor, or the Poisons Information Centre (telephone 13 11 26), or go to Accident and Emergency at the nearest hospital, if you think you or anyone else may have taken too much MOVALIS. Do this even if there are no signs of discomfort or poisoning.